Equity Analysis

Quarterly Results

    Aarti Pharmalabs Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543748
    INE0LRU01027
    188.3488351
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    AARTIPHARM
    27.16
    5598.87
    EPS(TTM)
    Face Value()
    Div & Yield %:
    22.75
    5
    0.49
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales377.29393.49414.82
Other Operating Income0.000.000.00
Other Income 2.952.115.69
Total Income380.24395.60420.50
Total Expenditure 292.52309.83307.47
PBIDT87.7285.77113.03
Interest 5.394.254.42
PBDT82.3381.52108.61
Depreciation18.8918.2917.32
Tax12.7911.5711.70
Fringe Benefit Tax0.000.000.00
Deferred Tax2.804.5116.57
Reported Profit After Tax47.8447.1463.02
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item47.8447.1463.02
EPS (Unit Curr.)5.285.206.95
EPS (Adj) (Unit Curr.)5.285.206.95
Calculated EPS (Unit Curr.)5.285.206.95
Calculated EPS (Adj) (Unit Curr.)5.285.206.95
Calculated EPS (Ann.) (Unit Curr.)21.1120.8127.82
Calculated EPS (Adj) (Ann.) (Unit Curr.)21.1120.8127.82
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity45.3145.3145.31
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)23.2521.8027.25
PBDTM(%)21.8220.7226.18
PATM(%)12.6811.9815.19
Dividend Per Share(Rs)0.000.000.00
Diluted EPS5.275.206.95